|Former name(s)||Journal of Anti-Aging Medicine|
|Edited by||Aubrey de Grey|
|Publisher||Mary Ann Liebert|
The editor-in-chief is Aubrey de Grey. The journal covers topics as cardiovascular aging, cell immortalization and senescence, cloning/embryonic stem cells, DNA damage/repair, growth factors, immunology, invertebrate lifespan, neurodegeneration, tissue engineering, public policy, gene targeting, gene therapy, and genomics.
Appreciations of the journal have been rather divergent, with editorial board member Michael R. Rose calling it "a heroic effort to jump-start research on postponing or slowing human aging", whereas others judge it as being "somewhat fringy" or "situated admittedly at the fringe of gerontology by taking the controversial stance that aging is ameliorable while demanding to be taken as serious science."
Abstracting and indexing
Rejuvenation Research is abstracted and indexed in:
- Current Contents/Clinical Medicine
- Science Citation Index Expanded
- EMBASE/Excerpta Medica
- CAB Abstracts
- Michael Robertson Rose (2005). The long tomorrow: how advances in evolutionary biology can help us postpone aging. Page 148. Oxford University Press. ISBN 0-19-517939-0.
- Joseph Hooper (2005) The prophet of immortality. Popular Science 266(1): 72.
- Mykytyn, Courtney E. (2008). "Medicalizing the optimal: Anti-aging medicine and the quandary of intervention". Journal of Aging Studies 22 (4): 313. doi:10.1016/j.jaging.2008.05.004.
- "Rejuvenation Research". 2012 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2013.